BEYOND AIR INC (XAIR) Fundamental Analysis & Valuation

NASDAQ:XAIR • US08862L2025

0.8458 USD
-0.01 (-1.54%)
Last: Mar 10, 2026, 12:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This XAIR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

XAIR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XAIR have multiple concerns. XAIR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. XAIR Profitability Analysis

1.1 Basic Checks

  • In the past year XAIR has reported negative net income.
  • XAIR had a negative operating cash flow in the past year.
  • In the past 5 years XAIR always reported negative net income.
  • XAIR had a negative operating cash flow in each of the past 5 years.
XAIR Yearly Net Income VS EBIT VS OCF VS FCFXAIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • XAIR has a Return On Assets of -84.30%. This is in the lower half of the industry: XAIR underperforms 76.09% of its industry peers.
  • With a Return On Equity value of -382.21%, XAIR is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -84.3%
ROE -382.21%
ROIC N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
XAIR Yearly ROA, ROE, ROICXAIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • With a Gross Margin value of 1.82%, XAIR is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for XAIR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAIR Yearly Profit, Operating, Gross MarginsXAIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. XAIR Health Analysis

2.1 Basic Checks

  • XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XAIR has been increased compared to 1 year ago.
  • Compared to 5 years ago, XAIR has more shares outstanding
  • XAIR has a worse debt/assets ratio than last year.
XAIR Yearly Shares OutstandingXAIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
XAIR Yearly Total Debt VS Total AssetsXAIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • XAIR has an Altman-Z score of -13.33. This is a bad value and indicates that XAIR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of XAIR (-13.33) is worse than 83.15% of its industry peers.
  • XAIR has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • XAIR has a worse Debt to Equity ratio (2.71) than 84.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF N/A
Altman-Z -13.33
ROIC/WACCN/A
WACC10.92%
XAIR Yearly LT Debt VS Equity VS FCFXAIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • XAIR has a Current Ratio of 5.12. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.12, XAIR is in the better half of the industry, outperforming 77.72% of the companies in the same industry.
  • XAIR has a Quick Ratio of 4.77. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
  • XAIR has a better Quick ratio (4.77) than 80.98% of its industry peers.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.77
XAIR Yearly Current Assets VS Current LiabilitesXAIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. XAIR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 74.48% over the past year.
  • Looking at the last year, XAIR shows a very strong growth in Revenue. The Revenue has grown by 129.04%.
  • The Revenue has been growing by 21.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)74.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
Revenue 1Y (TTM)129.04%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%104.66%

3.2 Future

  • XAIR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.55% yearly.
  • The Revenue is expected to grow by 80.94% on average over the next years. This is a very strong growth
EPS Next Y74.52%
EPS Next 2Y37.06%
EPS Next 3Y23.4%
EPS Next 5Y14.55%
Revenue Next Year105.93%
Revenue Next 2Y80.47%
Revenue Next 3Y95.34%
Revenue Next 5Y80.94%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XAIR Yearly Revenue VS EstimatesXAIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
XAIR Yearly EPS VS EstimatesXAIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. XAIR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XAIR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XAIR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAIR Price Earnings VS Forward Price EarningsXAIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAIR Per share dataXAIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XAIR's earnings are expected to grow with 23.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.06%
EPS Next 3Y23.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XAIR Dividend Analysis

5.1 Amount

  • No dividends for XAIR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XAIR Fundamentals: All Metrics, Ratios and Statistics

BEYOND AIR INC

NASDAQ:XAIR (3/10/2026, 12:23:48 PM)

0.8458

-0.01 (-1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-13
Earnings (Next)06-15
Inst Owners13.96%
Inst Owner Change-14.42%
Ins Owners4.39%
Ins Owner Change0%
Market Cap8.91M
Revenue(TTM)6.92M
Net Income(TTM)-31.00M
Analysts80
Price Target7.91 (835.21%)
Short Float %9.14%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.44%
Min EPS beat(2)-43.33%
Max EPS beat(2)0.46%
EPS beat(4)2
Avg EPS beat(4)-5.58%
Min EPS beat(4)-43.33%
Max EPS beat(4)27.68%
EPS beat(8)6
Avg EPS beat(8)3.95%
EPS beat(12)8
Avg EPS beat(12)-0.21%
EPS beat(16)9
Avg EPS beat(16)-9.81%
Revenue beat(2)1
Avg Revenue beat(2)-14.03%
Min Revenue beat(2)-28.34%
Max Revenue beat(2)0.27%
Revenue beat(4)1
Avg Revenue beat(4)-12.01%
Min Revenue beat(4)-28.34%
Max Revenue beat(4)0.27%
Revenue beat(8)2
Avg Revenue beat(8)-14.34%
Revenue beat(12)2
Avg Revenue beat(12)-30.25%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.89%
PT rev (3m)-13.89%
EPS NQ rev (1m)1.29%
EPS NQ rev (3m)-20.1%
EPS NY rev (1m)-6.96%
EPS NY rev (3m)-17.34%
Revenue NQ rev (1m)-11.14%
Revenue NQ rev (3m)-12.08%
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-5.41
EYN/A
EPS(NY)-1.92
Fwd EYN/A
FCF(TTM)-2.1
FCFYN/A
OCF(TTM)-1.91
OCFYN/A
SpS0.66
BVpS0.77
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -84.3%
ROE -382.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.82%
FCFM N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.56%
Cap/Sales 28.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.77
Altman-Z -13.33
F-Score5
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)311.89%
Cap/Depr(5y)350.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
EPS Next Y74.52%
EPS Next 2Y37.06%
EPS Next 3Y23.4%
EPS Next 5Y14.55%
Revenue 1Y (TTM)129.04%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%104.66%
Revenue Next Year105.93%
Revenue Next 2Y80.47%
Revenue Next 3Y95.34%
Revenue Next 5Y80.94%
EBIT growth 1Y41.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.49%
OCF growth 3YN/A
OCF growth 5YN/A

BEYOND AIR INC / XAIR FAQ

What is the fundamental rating for XAIR stock?

ChartMill assigns a fundamental rating of 3 / 10 to XAIR.


Can you provide the valuation status for BEYOND AIR INC?

ChartMill assigns a valuation rating of 1 / 10 to BEYOND AIR INC (XAIR). This can be considered as Overvalued.


How profitable is BEYOND AIR INC (XAIR) stock?

BEYOND AIR INC (XAIR) has a profitability rating of 0 / 10.


What is the financial health of BEYOND AIR INC (XAIR) stock?

The financial health rating of BEYOND AIR INC (XAIR) is 3 / 10.